As classical pathways downstream of RIPK2, NF-κB signaling and the well-known cancer associated MAPK signaling were evaluated to investigate the specific mechanisms responsible for the RIPK2 induced malignant phenotypes in PC (Fig. 8). The gene discussed is NFKB1; the disease is pachyonychia congenita.